ThermoGenesis Holdings Inc (THMO)
0.6000
+0.04
(+7.74%)
USD |
NASDAQ |
May 31, 16:00
0.567
-0.03
(-5.50%)
After-Hours: 20:00
ThermoGenesis Holdings Research and Development Expense (Quarterly): 0.211M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.211M |
| December 31, 2023 | 0.329M |
| September 30, 2023 | 0.266M |
| June 30, 2023 | 0.383M |
| March 31, 2023 | 0.306M |
| December 31, 2022 | 0.342M |
| September 30, 2022 | 0.47M |
| June 30, 2022 | 0.392M |
| March 31, 2022 | 0.456M |
| December 31, 2021 | 0.665M |
| September 30, 2021 | 0.543M |
| June 30, 2021 | 0.622M |
| March 31, 2021 | 0.379M |
| December 31, 2020 | 0.54M |
| September 30, 2020 | 0.75M |
| June 30, 2020 | 0.578M |
| March 31, 2020 | 0.609M |
| December 31, 2019 | 0.638M |
| September 30, 2019 | 0.584M |
| June 30, 2019 | 0.611M |
| March 31, 2019 | 0.563M |
| December 31, 2018 | 0.452M |
| September 30, 2018 | 0.611M |
| June 30, 2018 | 0.908M |
| March 31, 2018 | 1.041M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.063M |
| June 30, 2017 | 0.566M |
| March 31, 2017 | 0.567M |
| December 31, 2016 | 0.694M |
| September 30, 2016 | 0.67M |
| June 30, 2016 | 0.779M |
| March 31, 2016 | 0.708M |
| December 31, 2015 | 0.646M |
| September 30, 2015 | 1.097M |
| June 30, 2015 | 1.208M |
| March 31, 2015 | 1.712M |
| December 31, 2014 | 1.542M |
| September 30, 2014 | 1.477M |
| June 30, 2014 | 1.07M |
| March 31, 2014 | 0.768M |
| December 31, 2013 | 0.797M |
| September 30, 2013 | 0.833M |
| June 30, 2013 | 0.781M |
| March 31, 2013 | 0.658M |
| December 31, 2012 | 0.714M |
| September 30, 2012 | 0.838M |
| June 30, 2012 | 0.81M |
| March 31, 2012 | 0.959M |
| December 31, 2011 | 1.037M |
| September 30, 2011 | 0.923M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.211M
Minimum
Mar 2024
0.75M
Maximum
Sep 2020
0.4837M
Average
0.505M
Median
Research and Development Expense (Quarterly) Benchmarks
| Align Technology Inc | 91.86M |
| NeuroOne Medical Technologies Corp | 1.274M |
| SINTX Technologies Inc | 2.019M |
| Nutriband Inc | 0.5634M |
| enVVeno Medical Corp | 3.052M |